The water-based electronic cigarette technology developed by Aquios Labs and Innokin continues to make a significant impact on the e-cigarette industry.
The electronic cigarette industry forum and awards ceremony organized by the UK Vaping Industry Association (UKVIA) is an important date on the electronic cigarette industry calendar. On Friday, November 18, 2022, around 300 representatives including policy makers, tobacco harm reduction experts, and electronic cigarette industry representatives gathered to discuss the theme of the event, "Creating a Better Future with Electronic Cigarettes.
Recent accolades include being named "Best Overall E-cigarette Brand" at the 2021 Ecigclick Awards, receiving the "Best Sustainable Development Initiative" award at the 2022 Vapouround Awards, and winning the "Most Innovative Breakthrough" award at the 2022 Golden Leaf Awards. The latter was awarded for introducing water into the development of e-cigarette technology, in collaboration with Aquios Labs.
Innokin has announced the development of a new water-based electronic cigarette, aimed at delivering smoother vapor, faster satisfaction and more accurate flavor while increasing harm reduction potential. These advantages are achieved through the use of a proprietary e-liquid formula with a water content of 30%, combined with new electronic cigarette hardware customized for diluting liquids.
Now, Innokin and Aquios Labs have added another water-based e-cigarette, INNOBAR C1, to their product lineup, and showcased it to industry experts at the UKVIA forum.
The use of water-based technology in electronic cigarettes is rapidly gaining momentum in the global e-cigarette industry. Major brands and harm reduction experts are seeking new methods to enhance the effectiveness of e-cigarette products.
In the UKVIA forum "Innovation in the e-cigarette industry", Benedict Jones, brand manager of Innokin UK, stated: "The process of listening to customer feedback and understanding the challenges they face is at the core of our product strategy. Our goal has always been to reduce the barriers between transitioning smokers and less harmful alternatives.
By incorporating water-based atomization technology, the INNOBAR C1 is able to provide smoother vapor, higher nicotine satisfaction, and reduced dehydration at lower atomization temperatures, while also increasing chemical stability.
Innokin and Aquios Labs have recently launched several disposable electronic cigarette devices using water-based e-cigarette technology, as well as their latest pre-filled pod device, INNOBAR C1. Innokin and Aquios Labs plan to expand their unique water-based e-cigarette product line to cover all segments of the growing e-cigarette market.
Statement:
This article is compiled from third-party information and is intended for industry professionals for educational purposes only.
This article does not represent the views of 2FIRSTS, and 2FIRSTS cannot confirm the truthfulness or accuracy of the content. The translation of this article is only intended for industry communication and research purposes.
Due to limitations in the level of translation, the translated article may not fully reflect the content of the original. Please refer to the original article for accuracy.
2FIRSTS maintains complete alignment with the Chinese government with regards to any domestic, Hong Kong, Macao, Taiwan, or international expressions and positions.
The copyrights of the compiled information belong to the original media and authors. If there is an infringement, please contact us for removal.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
